Table of Content

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global ePharmacy Market

4. Market Overview
4.1. Introduction
4.1.1. Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global ePharmacy Market Analysis and Forecast, 2017–2031

5. Key Insights
5.1. Pricing Analysis
5.2. Key Industry Events (mergers, acquisitions, collaborations, approvals, etc.)
5.3. COVID-19 Impact Analysis
5.4. Regulatory Scenario

6. Global ePharmacy Market Analysis and Forecast, by Product
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Product, 2017–2031
6.3.1. Prescription Medicine
6.3.2. Over-the-counter (OTC) Products
6.3.3. Other (Diagnostic Services)
6.4. Market Attractiveness Analysis, by Product

7. Global ePharmacy Market Analysis and Forecast, by Region
7.1. Key Findings
7.2. Market Value Forecast, by Region
7.2.1. North America
7.2.2. Europe
7.2.3. Asia Pacific
7.2.4. Latin America
7.2.5. Middle East & Africa
7.3. Market Attractiveness Analysis, by Region

8. North America ePharmacy Market Analysis and Forecast
8.1. Introduction
8.1.1. Key Findings
8.2. Market Value Forecast, by Product, 2017–2031
8.2.1. Prescription Medicine
8.2.2. Over-the-counter (OTC) Products
8.2.3. Other
8.3. Market Value Forecast, by Country, 2017–2031
8.3.1. U.S.
8.3.2. Canada
8.4. Market Attractiveness Analysis
8.4.1. By Product
8.4.2. By Country

9. Europe ePharmacy Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. Market Value Forecast, by Product, 2017–2031
9.2.1. Prescription Medicine
9.2.2. Over-the-counter (OTC) Products
9.2.3. Other
9.3. Market Value Forecast, by Country/Sub-region, 2017–2031
9.3.1. Germany
9.3.2. U.K.
9.3.3. France
9.3.4. Italy
9.3.5. Spain
9.3.6. Rest of Europe
9.4. Market Attractiveness Analysis
9.4.1. By Product
9.4.2. By Country/Sub-region

10. Asia Pacific ePharmacy Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Product, 2017–2031
10.2.1. Prescription Medicine
10.2.2. Over-the-counter (OTC) Products
10.2.3. Other
10.3. Market Value Forecast, by Country/Sub-region, 2017–2031
10.3.1. China
10.3.2. Japan
10.3.3. India
10.3.4. Australia & New Zealand
10.3.5. Rest of Asia Pacific
10.4. Market Attractiveness Analysis
10.4.1. By Product
10.4.2. By Country/Sub-region

11. Latin America ePharmacy Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product, 2017–2031
11.2.1. Prescription Medicine
11.2.2. Over-the-counter (OTC) Products
11.2.3. Other
11.3. Market Value Forecast, by Country/Sub-region, 2017–2031
11.3.1. Brazil
11.3.2. Mexico
11.3.3. Rest of Latin America
11.4. Market Attractiveness Analysis
11.4.1. By Product
11.4.2. By Country/Sub-region

12. Middle East & Africa ePharmacy Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product, 2017–2031
12.2.1. Prescription Medicine
12.2.2. Over-the-counter (OTC) Products
12.2.3. Other
12.3. Market Value Forecast, by Country/Sub-region, 2017–2031
12.3.1. GCC Countries
12.3.2. South Africa
12.3.3. Rest of Middle East & Africa
12.4. Market Attractiveness Analysis
12.4.1. By Product
12.4.2. By Country/Sub-region

13. Competition Landscape
13.1. Market Player - Competitive Matrix (by tier and size of companies
13.2. Market Share Analysis, by Company (2021)
13.3. Company Profiles
13.3.1. Chemist Direct
13.3.1.1. Company Overview
13.3.1.2. Product Portfolio
13.3.1.3. SWOT Analysis
13.3.1.4. Financial Overview
13.3.1.5. Strategic Overview
13.3.2. DocMorris
13.3.2.1. Company Overview
13.3.2.2. Product Portfolio
13.3.2.3. SWOT Analysis
13.3.2.4. Financial Overview
13.3.2.5. Strategic Overview
13.3.3. Express Scripts Holding Company
13.3.3.1. Company Overview
13.3.3.2. Product Portfolio
13.3.3.3. SWOT Analysis
13.3.3.4. Financial Overview
13.3.3.5. Strategic Overview
13.3.4. Giant Eagle, Inc.
13.3.4.1. Company Overview
13.3.4.2. Product Portfolio
13.3.4.3. SWOT Analysis
13.3.4.4. Financial Overview
13.3.4.5. Strategic Overview
13.3.5. Healthxchange Pharmacy
13.3.5.1. Company Overview
13.3.5.2. Product Portfolio
13.3.5.3. SWOT Analysis
13.3.5.4. Financial Overview
13.3.5.5. Strategic Overview
13.3.6. LloydsPharmacy
13.3.6.1. Company Overview
13.3.6.2. Product Portfolio
13.3.6.3. SWOT Analysis
13.3.6.4. Financial Overview
13.3.6.5. Strategic Overview
13.3.7. MedExpress
13.3.7.1. Company Overview
13.3.7.2. Product Portfolio
13.3.7.3. SWOT Analysis
13.3.7.4. Financial Overview
13.3.7.5. Strategic Overview
13.3.8. Netmeds
13.3.8.1. Company Overview
13.3.8.2. Product Portfolio
13.3.8.3. SWOT Analysis
13.3.8.4. Financial Overview
13.3.8.5. Strategic Overview
13.3.9. Optum Rx, Inc.
13.3.9.1. Company Overview
13.3.9.2. Product Portfolio
13.3.9.3. SWOT Analysis
13.3.9.4. Financial Overview
13.3.9.5. Strategic Overview
13.3.10. PharmEasy
13.3.10.1. Company Overview
13.3.10.2. Product Portfolio
13.3.10.3. SWOT Analysis
13.3.10.4. Financial Overview
13.3.10.5. Strategic Overview
13.3.11. 1Mg
13.3.11.1. Company Overview
13.3.11.2. Product Portfolio
13.3.11.3. SWOT Analysis
13.3.11.4. Financial Overview
13.3.11.5. Strategic Overview
13.3.12. Rowlands Pharmacy
13.3.12.1. Company Overview
13.3.12.2. Product Portfolio
13.3.12.3. SWOT Analysis
13.3.12.4. Financial Overview
13.3.12.5. Strategic Overview
13.3.13. The Kroger Co.
13.3.13.1. Company Overview
13.3.13.2. Product Portfolio
13.3.13.3. SWOT Analysis
13.3.13.4. Financial Overview
13.3.13.5. Strategic Overview
13.3.14. Walgreen Co.
13.3.14.1. Company Overview
13.3.14.2. Product Portfolio
13.3.14.3. SWOT Analysis
13.3.14.4. Financial Overview
13.3.14.5. Strategic Overview
13.3.15. Well Pharmacy
13.3.15.1. Company Overview
13.3.15.2. Product Portfolio
13.3.15.3. SWOT Analysis
13.3.15.4. Financial Overview
13.3.15.5. Strategic Overview



List of Figures

List of Figures

Figure 01: Global ePharmacy Market Size (US$ Mn) and Distribution (%), by Region, 2017 and 2031

Figure 02: Global ePharmacy Market Revenue (US$ Mn), by Product, 2021

Figure 03: Global ePharmacy Market Value Share, by Product, 2021

Figure 04: Global ePharmacy Market Value Share, by Region, 2021

Figure 05: Global ePharmacy Market Value (US$ Mn) Forecast, 2017–2031

Figure 06: Global ePharmacy Market Value Share Analysis, by Product, 2017 and 2031

Figure 07: Global ePharmacy Market Attractiveness Analysis, by Product, 2022-2031

Figure 08: Global ePharmacy Market Attractiveness Analysis, by Region, 2022-2031

Figure 09: North America ePharmacy Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

Figure 10: North America ePharmacy Market Attractiveness Analysis, by Country, 2017–2031

Figure 11: North America ePharmacy Market Value Share Analysis, by Country, 2017 and 2031

Figure 12: North America ePharmacy Market Value Share Analysis, by Product, 2017 and 2031

Figure 13: North America ePharmacy Market Attractiveness Analysis, by Product, 2022–2031

Figure 14: Europe ePharmacy Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

Figure 15: Europe ePharmacy Market Attractiveness Analysis, by Country/Sub-region, 2017–2031

Figure 16: Europe ePharmacy Market Value Share Analysis, by Country/Sub-region, 2017 and 2031

Figure 17: Europe ePharmacy Market Value Share Analysis, by Product, 2017 and 2031

Figure 18: Europe ePharmacy Market Attractiveness Analysis, by Product, 2022–2031

Figure 19: Asia Pacific ePharmacy Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

Figure 20: Asia Pacific ePharmacy Market Attractiveness Analysis, by Country/Sub-region, 2017–2031

Figure 21: Asia Pacific ePharmacy Market Value Share Analysis, by Country/Sub-region, 2017 and 2031

Figure 22: Asia Pacific ePharmacy Market Value Share Analysis, by Product, 2017 and 2031

Figure 23: Asia Pacific ePharmacy Market Attractiveness Analysis, by Product, 2022–2031

Figure 24: Latin America ePharmacy Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

Figure 25: Latin America ePharmacy Market Attractiveness Analysis, by Country/Sub-region, 2017–2031

Figure 26: Latin America ePharmacy Market Value Share Analysis, by Country/Sub-region, 2017 and 2031

Figure 27: Latin America ePharmacy Market Value Share Analysis, by Product, 2017 and 2031

Figure 28: Latin America ePharmacy Market Attractiveness Analysis, by Product, 2022–2031

Figure 29: Middle East & Africa ePharmacy Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

Figure 30: Middle East & Africa ePharmacy Market Attractiveness Analysis, by Country/Sub-region, 2017–2031

Figure 31: Middle East & Africa ePharmacy Market Value Share Analysis, by Country/Sub-region, 2017 and 2031

Figure 32: Middle East & Africa ePharmacy Market Value Share Analysis, by Product, 2017 and 2031

Figure 33: Middle East & Africa ePharmacy Market Attractiveness Analysis, by Product, 2022–2031

List of Tables

List of Tables

Table 01: Global ePharmacy Market Size (US$ Mn) Forecast, by Product, 2017–2031

Table 02: Global ePharmacy Market Size (US$ Mn) Forecast, by Region, 2017–2031

Table 03: North America ePharmacy Market Size (US$ Mn) Forecast, by Country, 2017–2031

Table 04: North America ePharmacy Market Size (US$ Mn) Forecast, by Product, 2017–2031

Table 05: Europe ePharmacy Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 06: Europe ePharmacy Market Size (US$ Mn) Forecast, by Product, 2017–2031

Table 07: Asia Pacific ePharmacy Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 08: Asia Pacific ePharmacy Market Size (US$ Mn) Forecast, by Product, 2017–2031

Table 09: Latin America ePharmacy Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 10: Latin America ePharmacy Market Size (US$ Mn) Forecast, by Product, 2017–2031

Table 11: Middle East & Africa ePharmacy Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 12: Middle East & Africa ePharmacy Market Size (US$ Mn) Forecast, by Product, 2017–2031